March 5, 2020
Takeda Pharmaceutical said on March 4 that it has completed the sale of some 20 non-core OTC and prescription drugs marketed in Russia and former Soviet states to Germany’s Stada Arzneimittel for US$660 million. Stada has now acquired the select...read more